相关实验视频
Updated: May 12, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.5K
PCSK9通过E-cadherin内细胞分裂促进了对抗性甲状腺癌的进展
Yu Zhang1,2, Wei Su2,3, Xiaoyu Ji4
1Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Cell death & disease
|May 6, 2025
概括
蛋白转化酶亚提利辛/凯类型9 (PCSK9) 通过降解E-cadherin来驱动类型9甲状腺癌 (ATC) 恶性病. 用PF-846抑制PCSK9抑制了ATC生长和转移,突出显示PCSK9是潜在的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 无塑性甲状腺癌 (ATC) 是一种罕见但极具致命性的甲状腺恶性瘤.
- 了解推动ATC进展的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 调查蛋白转化酶亚提利辛/凯类型9 (PCSK9) 在厌塑性甲状腺癌 (ATC) 进展中的作用.
- 确定针对ATC中的PCSK9的治疗策略.
主要方法:
- 蛋白质组分析以确定关键介质.
- 研究PCSK9对E-cadherin的作用的分子机制.
- 通过p53突变评估PCSK9的调节.
- 在体外和体内对PCSK9抑制剂PF-846.6的评估.
主要成果:
- PCSK9被确定为ATC恶性瘤的关键驱动因素.
- PCSK9通过 lysosomal 途径促进 E-cadherin 的降解.
- 失去p53功能,特别是R248Q突变,可以通过转录上调PCSK9.
- 在临床前模型中,PF-846显著抑制了ATC的扩散和转移.
结论:
- 通过E-cadherin调节,PCSK9增强了ATC恶性瘤.
- PCSK9代表了对形甲状腺癌的有前途的治疗标.
相关概念视频
Cadherins in Tissue Organization
2.9K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
2.9K
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K

